ClinicalTrials.Veeva

Menu

Towards an Early Integration of Palliative Care in Oncology (BESACE)

A

Assistance Publique - Hôpitaux de Paris

Status

Completed

Conditions

Metastatic Cancer
Palliatives Treatments

Study type

Observational

Funder types

Other

Identifiers

NCT05339945
2021-A01007-34 (Registry Identifier)
APHP210724

Details and patient eligibility

About

The primary objective of the study is to describe the nature and to estimate the prevalence the health needs of patients with metastatic cancer and their main caregivers, between the period from diagnosis to death.

As secondary objectives, the study aims:

  • to determinate the proportion of patients with an indication for palliative care according to Hui et al., and to describe the adequation of health needs and the services for them;
  • to study the association between clinical pathway and the indication of targeted palliative care;
  • to study the association between the integration of palliative care service and the adequation of health needs service of patients;
  • to study the factors such as the disease, the practice and the care, contribute to the patient's survivor of 1 year.

Full description

This is a descriptive, transversal, multicenter study, which will be performed in healthcare facilities in Ile de France area.

Each investigator center will be composed by oncologist / palliative care and support team. 10 centers will participate to the study, enrollement will be perfomed during 6 months targetting 400 patients with advanced cancer.

Enrollment

361 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients ≥ 18 years;
  • Diagnosed metastatic cancer;
  • Outpatient or inpatient care at a participating site to the study;
  • Affiliation to the social security scheme;
  • Patient informed and non-opposed to participate to the study.

Exclusion criteria

  • Testicular or choriocarcinoma ovarian cancer;
  • Hematology cancer;
  • No understanding french language;
  • Unable to express if needed his non-opposition opinion, according to physician investigator;
  • Visually impaired, hearing impaired or aphasic.

Trial contacts and locations

1

Loading...

Central trial contact

Marine SAHUT D'IZARN, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems